Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Incomplete posterior vitreous detachment raises retinal detachment risk post-lens surgery
  • Retina

Incomplete posterior vitreous detachment raises retinal detachment risk post-lens surgery

Kelsey Moroz

Myopic eyes with incomplete or absent posterior vitreous detachment (PVD) before lens surgery are at a significantly higher risk of developing retinal detachment (RD) in the postoperative period compared to eyes with complete PVD, according to a poster presented at the 42nd Congress of the ESCRS.

The study tracked 618 eyes with an axial length of ≥ 25.0 mm scheduled for lens surgery over 3 years, as well fellow eyes.

Out of the 939 eyes observed, 13 cases of RD were reported—8 in the study group and 5 in fellow eyes. The cumulative incidence rates were 0.83% at 1 year, 1.31% at 2 years, and 1.56% at 3 years. Of note, eyes with complete PVD at baseline exhibited significantly lower RD rates (0.22% at 1 year vs 0.44% at 3 years) than those with incomplete or no PVD (1.65% at 1 year vs 3.04% at 3 years).

The study concluded that having incomplete or absent PVD before surgery markedly raised the risk of RD, with an unadjusted hazard ratio of 5.62. After adjusting for age, the risk was slightly reduced to a hazard ratio of 4.12.

Reference
Ullrich M, et al. Influence of posterior vitreous detachment on retinal detachment after lens surgery in myopic eyes: 3-year results of the ESCRS MYOPRED study. Poster presented at: 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS); September 6-10, 2024; Barcelona, Spain.

Share

Related Content

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Retina

Alternative aflibercept regimens maintained efficacy in wet AMD

  • Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon